Mabion is the leading, polish biotechnology company founded in order to develop technology of biotechnological medicines production (based on the therapeutic monoclonal antibodies) and launch them on the market.The technology, independently developed in Mabion, enables production of targeted medicines that act selectively on cause of disease for example cancer cells, providing better efficiency and lower toxicity of the therap...
Mabion is the leading, polish biotechnology company founded in order to develop technology of biotechnological medicines production (based on the therapeutic monoclonal antibodies) and launch them on the market.The technology, independently developed in Mabion, enables production of targeted medicines that act selectively on cause of disease for example cancer cells, providing better efficiency and lower toxicity of the therapy. Products under development: MabionCD20 biosimilar to MabThera, MabionHER2 biosimilar to Herceptin, MabionVEGF biosimilar to Avastin, MabionEGFR biosimilar to Erbitux, insulins and insulin analogs
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.